|
|
|
Insider
Information: |
Silvernail Lauren P |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
207,068 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,091,195 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
207,068 |
|
|
Total
Value |
$2,091,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-60.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ISTA Pharmaceuticals Inc |
ISTA |
CFO & VP Corporate Dev... |
2012-06-06 |
0 |
2005-05-12 |
0 |
Premium* |
|
Revance Therapeutics, Inc. |
RVNC |
CFO & CBO |
2018-05-22 |
65,497 |
2014-05-19 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
See Remarks |
2022-05-18 |
141,571 |
2018-05-29 |
0 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ISTA |
ISTA Pharmaceuticals Inc |
CFO & VP Corporate Development |
|
2012-06-06 |
4 |
D |
$9.10 |
$1,702,983 |
D/D |
(187,141) |
0 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
|
|
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2015-06-30 |
4 |
A |
$14.16 |
$8,963 |
D/D |
633 |
633 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2005-05-12 |
4 |
B |
$7.51 |
$37,699 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2006-02-16 |
4 |
A |
$0.00 |
$6 |
D/D |
5,600 |
10,600 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2006-02-16 |
4 |
A |
$0.00 |
$6 |
D/D |
5,600 |
12,721 |
|
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Seretary & EVP Corp Dev. |
|
2014-05-19 |
4 |
A |
$32.22 |
$451,080 |
D/D |
14,000 |
14,000 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2014-12-11 |
4 |
B |
$17.73 |
$17,383 |
D/D |
980 |
14,980 |
2.74 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-04 |
4 |
D |
$5.27 |
$4,379 |
D/D |
(831) |
16,269 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-04 |
4/A |
D |
$5.27 |
$3,937 |
D/D |
(747) |
16,353 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2007-02-16 |
4 |
D |
$8.11 |
$4,055 |
D/D |
(500) |
17,100 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2007-02-02 |
4 |
A |
$0.00 |
$7 |
D/D |
7,000 |
17,600 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2015-05-19 |
4 |
D |
$25.94 |
$45,473 |
D/D |
(1,753) |
21,517 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2016-01-28 |
4 |
D |
$20.30 |
$21,579 |
D/D |
(1,063) |
21,695 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2015-12-31 |
4 |
A |
$27.00 |
$9,153 |
D/D |
339 |
22,758 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,290 |
23,270 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-19 |
4 |
D |
$4.56 |
$2,280 |
D/D |
(500) |
26,269 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-08 |
4 |
A |
$0.00 |
$11 |
D/D |
10,500 |
26,769 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2019-05-31 |
4 |
S |
$13.53 |
$35,352 |
D/D |
(2,612) |
27,388 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2016-05-19 |
4 |
D |
$17.11 |
$29,994 |
D/D |
(1,753) |
29,942 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2016-06-30 |
4 |
A |
$11.56 |
$8,658 |
D/D |
749 |
30,691 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2016-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,695 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2017-05-22 |
4 |
S |
$20.20 |
$36,212 |
D/D |
(1,793) |
36,566 |
0 |
- |
|
78 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|